You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

estramustine combine to docetaxel

Showing 1 - 25 of 2,876
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in France (drug, procedure, radiation)

Completed
  • Prostate Cancer
  • Angers, France
  • +37 more
Jan 17, 2023

Efficiency Between Intraoperative and Postoperative Hyperthermic

Not yet recruiting
  • Stomach Neoplasms
  • Hyperthermic Intraperitoneal Chemotherapy
  • intraoperative or postoperative hyperthermic intraperitoneal chemotherapy
  • Xi'an, Shannxi, China
    Kun Zhu
Aug 19, 2020

Prostate Cancer, Prostate Tumors, Tumors, Prostatic Trial run by the NCI (PROSTVAC-V, PROSTVAC-F, Docetaxel)

Active, not recruiting
  • Prostate Cancer
  • +2 more
  • PROSTVAC-V
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 14, 2022

Stage III Breast Cancer AJCC V7 Trial in Bergen (epirubicin/docetaxel sequential)

Active, not recruiting
  • Stage III Breast Cancer AJCC V7
  • epirubicin/docetaxel sequential
  • Bergen, Norway
    Dept of Oncology
Jun 24, 2022

Metastatic Castrate Resistant Prostate Cancer Trial in Boston, Detroit, Columbus (Docetaxel, Radium 223)

Recruiting
  • Metastatic Castrate Resistant Prostate Cancer
  • Boston, Massachusetts
  • +3 more
Feb 22, 2022

Non-small Cell Lung Adenocarcinoma, Squamous Cell Carcinoma of Lung Trial in Guangzhou (SI-B001, Docetaxel)

Not yet recruiting
  • Non-small Cell Lung Adenocarcinoma
  • Squamous Cell Carcinoma of Lung
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 5, 2023

Gastric Cancer Trial in Beijing (RC48-ADC, Herceptin, Toripalimab)

Not yet recruiting
  • Gastric Cancer
  • Beijing, China
    Beijing Cancer Hospital
Aug 7, 2023

Serplulimab,Gastric Cancer, Adjuvant Therapy Trial in Shanghai (Serplulimab, Docetaxel, S1)

Recruiting
  • Serplulimab,Gastric Cancer, Adjuvant Therapy
  • Shanghai, China
    Zhang Zizhen
Mar 3, 2023

Prostatic Adenocarcinoma Trial in Seoul (Enzalutamide)

Not yet recruiting
  • Prostatic Adenocarcinoma
  • Seoul, Korea, Korea, Republic of
    Samsung Medical Center
Aug 23, 2023

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Sep 20, 2023

Advanced NSCLC Trial (Trilaciclib+Envafolimab+Docetaxel, Envafolimab+Docetaxel, Docetaxel)

Not yet recruiting
  • Advanced Non-Small Cell Lung Cancer
  • (no location specified)
Jun 16, 2023

Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV Trial in Worldwide (Selumetinib, Docetaxel, Placebo)

Active, not recruiting
Has Results
  • Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
  • Aurora, Colorado
  • +196 more
Dec 22, 2022

HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients Trial (PERT-IJS plus trastuzumab,

Not yet recruiting
  • HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
  • PERT-IJS plus trastuzumab, carboplatin and docetaxel
  • Perjeta plus trastuzumab, carboplatin and docetaxel
  • (no location specified)
Sep 21, 2023

Prostate Cancer, Prostate Adenocarcinoma Trial in Charlotte (ADT+Docetaxel+Enzalutamide)

Active, not recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Charlotte, North Carolina
    Levine Cancer Institute
Jan 12, 2023

Breast Cancer Trial in Rouen (pharmacokinetics blood sample assessment)

Not yet recruiting
  • Breast Cancer
  • pharmacokinetics blood sample assessment
  • Rouen, France
    Centre Henri Becquerel
May 11, 2023

Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Tumors, Prostate Cancer Recurrent Trial (lorigerlimab,

Not yet recruiting
  • Androgen-Independent Prostatic Cancer
  • +8 more
  • lorigerlimab
  • +2 more
  • (no location specified)
May 4, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Bellinzona, Chur, St. Gallen (Docetaxel micellar)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Docetaxel micellar
  • Bellinzona, Switzerland
  • +2 more
Nov 7, 2022

NSCLC Trial in Australia, China, United States (Docetaxel + Plinabulin (DP), Docetaxel (D))

Completed
  • Non-Small Cell Lung Cancer
  • Docetaxel + Plinabulin (DP)
  • Docetaxel (D)
  • Chandler, Arizona
  • +56 more
Sep 9, 2022

Tumors Trial in Worldwide (Docetaxel, Feladilimab)

Completed
Has Results
  • Neoplasms
  • Saint Louis, Missouri
  • +42 more
Dec 22, 2022

Pain, Postoperative Trial in Taipei City (Naldebain, SafeTynadol, Naldebain + SafeTynadol)

Not yet recruiting
  • Pain, Postoperative
  • Taipei City, Beitou District, Taiwan
    Taipei Veterans General Hospital
May 3, 2023

Prostate Cancer Trial in Netherlands, United States (Docetaxel 75 mg/m2, Docetaxel 60 mg/m2, Radium-223)

Recruiting
  • Prostate Cancer
  • Docetaxel 75 mg/m2
  • +2 more
  • Gilbert, Arizona
  • +52 more
Feb 2, 2023

Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

Recruiting
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in United States

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Duarte, California
  • +22 more
Jan 3, 2023

Breast Cancer Trial in Shanghai (Pegylated liposomal doxorubicin, Epirubicin, Cyclophosphamid)

Recruiting
  • Breast Cancer
  • Pegylated liposomal doxorubicin
  • +5 more
  • Shanghai, China
    Shanghai Pudong Hospital
Dec 11, 2022

Prostatic Tumors Trial in Worldwide (Pembrolizumab, Docetaxel, Prednisone)

Active, not recruiting
  • Prostatic Neoplasms
  • Pembrolizumab
  • +4 more
  • Mobile, Alabama
  • +214 more
Nov 24, 2022